NCT06157671View on ClinicalTrials.gov

The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma

Enrolling by invitationOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

January 1, 2030

Study Completion Date

June 1, 2030

Conditions
Pancreatic AdenocarcinomaPancreatic Intraepithelial Neoplasia
Trial Locations (1)

10017

Manhattan Endoscopy Center, New York

All Listed Sponsors
lead

Adenocyte, LLC

INDUSTRY